Skip to main content

TableĀ 2 Univariate and multivariate Cox hazards analysis between clinical features and OS

From: Development and validation of a prognostic nomogram in gastric cancer with hepatitis B virus infection

Characteristics

Univariate analysis

Multivariate analysis

HR (95% CI)

P-value

HR (95% CI)

P-value

Age, year

2.197 (1.177–4.101)

0.013

2.278 (1.172–4.428)

0.015

Sex

Ā Male/female

0.848 (0.503–1.429)

0.535

Ā Ā 

TNM stage

Ā I/II/III/IV

3.135 (2.280–4.310)

< 0.001

Ā Ā 

Tumor stage

Ā T1/T2/T3/T4

1.481 (1.074–2.043)

0.017

1.801 (1.293–2.510)

0.001

Node stage

Ā N0/N1/N2/N3

1.317 (1.019–1.701)

0.035

Ā Ā 

Metastasis

Ā No/yes

4.753 (2.732–8.268)

< 0.001

5.164 (2.912–9.157)

< 0.001

Location

Ā 1/2/3/4

0.958 (0.732–1.254)

0.757

Ā Ā 

AST, U/L

 ≤ 22.8/> 22.8

1.511 (0.934–2.446)

0.093

Ā Ā 

ALT, U/L

 ≤ 30.1/> 30.1

0.558 (0.267–1.168)

0.122

Ā Ā 

LDH, U/L

 ≤ 168.7/> 168.7

2.026 (1.252–3.281)

0.004

Ā Ā 

GGT, U/L

 ≤ 26.9/> 26.9

3.157 (1.929–5.167)

0.001

2.093 (1.223–3.581)

0.007

TBA, μmol/L

 ≤ 5.4/> 5.4

2.065 (1.277–3.339)

0.003

Ā Ā 

ALP, U/L

 ≤ 80/> 80

3.393 (2.093–5.499)

< 0.001

2.161 (1.271–3.672)

0.004

ALB, g/L

 ≤ 38.8/> 38.8

0.541 (0.316–0.837)

0.007

Ā Ā 

TBIL, μmol/L

 ≤ 7.3/> 7.3

0.623 (0.369–1.053)

0.077

Ā Ā 

ApoA1, g/L

 ≤ 1.1/> 1.1

0.564 (0.243–1.309)

0.182

Ā Ā 

ApoB, g/L

 ≤ 1.1/> 1.1

2.056 (1.101–3.841)

0.024

Ā Ā 

PT, S

 ≤ 11.9/> 11.9

1.464 (0.886–2.419)

0.137

Ā Ā 

Fbg, g/L

 ≤ 3.6/> 3.6

1.876 (1.052–3.346)

0.033

Ā Ā